Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
CHA Submits Letter on New NPI and Provider-Based Attestation Requirements
The letter emphasizes that the requirements would impose significant administrative, billing, and operational burden on children's hospitals.
May 26, 2026
CHA Comments on CMS State Directed Payment Proposed Rule on Children’s Health
Limits on SDPs will impact children’s access to care
May 21, 2026
This Is What Happens When Coordination Counts as Care
A state-funded enhanced care management program significantly reduced pediatric hospital stays and emergency department visits.
May 21, 2026
